Cancer development in man appeared to be a multistage process as suggested by epidemiological studies on commonly occurring gastric, colon, and breast cancers and also on human retrovirus-related leukemia, and by the finding by physicians and surgeons of precancerous lesions for many types of neoplasias. In the last 10 years it has become evident that human cancers have multiple genetic alterations caused by point mutations, recombinations, amplifications, and/or deletions. The genes affected include both oncogenes and tumorsuppressor genes and genes that accelerate cell proliferation and metastasis. Cancers with more malignant properties and poorer prognosis are generally associated with larger numbers of genetic alterations. These multiple genetic alterations are considered to be a direct reflection of the multiple steps involved in carcinogenesis. The multiple genetic alterations are caused by multiple environmental carcinogenic substances or factors, each of which usually exists only at minute concentrations and does not exert any major impact alone except under particular occupational, iatrogenic, and locally geographic conditions. The fact that carcinogenesis is a multistep process involving multiple genetic alterations clearly needs to be taken into consideration in assessing the risks of environmental carcinogenic substances or factors. The increasing incidence of multiple primary cancers is also most easily understood from the viewpoint of multiple steps in carcinogenesis. Possible multiple approaches to cancer prevention should therefore be considered in relation to multistep carcinegenesis and multiple carcinogenic factors.
Introduction
The existence of multiple steps in carcinogenesis was predicted by Rous and his associates from careful observations in animal experiments almost a half century ago (1) . Armitage and Doll also reached the same conclusion from analysis of the age distributions of common cancers in humans in 1954 (2) . More recently, it was similarly suggested on the basis of age distribution of patients that several events are required between initial HTLV-1 infection and onset of adult T-cell leukemia (ATL) (3) . Moreover, two-step carcinogenesis in the dorsal skin of mice by a single application of a limited amount of carcinogenic polycyclic aromatic hydrocarbon followed by repeated application of croton oil was demonstrated by Berenblum and Shubik in 1947 (4) .
The importance of genetic alterations in somatic cells in cancer development was described by Bauer in 1928 (5) . However, in 1914 Boveri predicted the function of oncogenes, using the term "chromosomes which promote division," and the inactivation of tumor-suppressor genes by saying that "inhibition chromosomes were eliminated" in his book (6) . In the last 20 years, molecular biological studies have clearly revealed the existence of many oncogenes and tumor-suppressor genes and their respective activation and inactivation among many types of cancers.
Multiple Genetic Alterations
The occurrence of more than one alteration of cancerrelated genes, namely, N-ras activation and c-myc amplification in cultured HL-60 cells, was first observed by Weinberg and associates (7) . Subsequently, Taya et al. demonstrated K-ras mutation and c-myc amplification in a human lung giant-cell carcinoma, Lu-65 (8) . Yamada et al. first demonstrated the coexistence of a mutation in K-ras, amplification of mutated K-ras, and amplification of c-myc in human pancreatic cancer without passing through cell culture (9) . Loss of heterozygosity (LOH) of chromosomes 3p, 13q, and 17p was first observed by Yokota et al. in human small-cell lung cancers (10) . The genes responsible for the alterations of chromosomes 13q and 17p were the Rb and p53 genes, respectively, while that on chromosome 3p was suggested to be a gene for a receptor-type protein tyrosine phosphatase -y (11) , although the possible contribution of other genes was also envisaged. Vogelstein et al. demonstrated the involvement of multiple genes in human colon carcinogenesis, detecting point mutations of K-ras, N-ras, and allelic deletion of chromosomes 5q, 17p, and 18q (12) (17) . The involvement of a gene on chromosome 5q in familial polyposis of the colon was first reported by Bodmer's group (18) . During in vivo progress from normal epithelium to hyperproliferation epithelium, early adenoma, intermediate adenoma, late adenoma, and carcinoma sequence, the frequencies of LOH of chromosome 5q, K-ras activation, and LOHs of chromosomes of 17p and 18q increase (17) . The gene on chromosome 18q was identified by Fearon et (20, 21 ), Nakamura's (22) , and White's (23, 24) (32) . The c-erbB-2 oncogene is often amplified in intestinal-type adenocarcinomas of the stomach, but not in scirrhous-type malignant lesions in the same organ (33) . The K-sam oncogene, encoding a tyrosine kinase receptor, is amplified in scirrhous-type adenocarcinomas, signet-ring-cell carcinomas, and mucinous adenocarcinomas, but not in the intestinal type of stomach cancer (34, 35) . This K-sam gene was originally isolated as an amplified gene in KATO III cells, derived from a signet-ring-cell carcinoma of the stomach (34, 36) . In 50% of the esophageal cancers and 15% of the breast cancers examined, the chromosome 11q13 locus, containing the HST1 and INT2 genes, was found to be amplified, but almost none were found in the stomach cancers (37, 38) . Study of molecular mechanisms underlying genetic alteration is important for establishing etiology of cancers among various organs.
Information on specificities of multiple genetic alterations should thus provide clues as to why cancer development occurs in particular organs. For instance, analysis of mutation site and base change for hepatomas in aflatoxin Bl-contaminated and noncontaminated areas suggested different patterns in the mechanism of mutation in p53 genes (39, 40) . Interestingly, cholangiocarcinomas in Japan are frequently associated with K-ras activation, but those in Thailand, which resulted in part from liver fluke infection, have no K-ras mutation, whereas both show the same frequency of mutation of the p53 gene (Tsuda and Hirohashi, unpublished data).
Multiple Environmental Carcinogens, Carcinogenic Factors, and Carcinogenic Conditions
The multiple genetic alterations in carcinomas are presumably caused by multiple kinds of environmental xenobiotics and autobiotics. As xenobiotics, polycyclic aromatic hydrocarbons, N-nitrosamines, mycotoxins, and heterocyclic amines are typical genotoxic carcinogens. However, the extent of exposure to any one of such chemicals is generally thought to be very small in comparison with their effective doses for producing cancers in rodents in standard long-term carcinogenesis experiments. It should be true for exposures to ionizing radiation and ultraviolet light. Autobiotic genotoxic agents such as oxygen radicals can also modify DNA bases, as represented by the formation of 8-hydroxyguanine and thymine glycol (41, 42) . In addition, nitric oxide synthase produces NO from L-arginine, this NO being involved in endogenous formation of nitrosamine compounds (43) (44) (45) as well as inducing deamination of 5-methylcytosine residues of DNA to produce thymine residues, resulting in transition of C to T after replication of DNA (46) . With all the compounds described above as examples, DNA damage is caused, which could lead to genetic alteration in somatic cells.
The fidelity of DNA replication and equal distribution of the genome between daughter cells both involve some possibility of genetic alterations, and cell proliferation itself might be expected to increase the chances of'thege genetic alterations occurring. Cell turnover in healthy resting-cell populations can be induced by viral or bacterial infection, mechanical tissue damage, and inflammatory reactions. The structure of the hepatitis C virus (HCV) was recently fully elucidated (4 7,48) , and HCV infection causes chronic hepatitis associated with death of hepatic cells and their compensatory regeneration. However, genomic integration of the HCV genome has not so far been observed. Instead, hepatic cells that undergo many generations through repeated cell divisions are more likely to accumulate genetic alterations by chance. This condition could be termed "local aging" or "topographic senescence" limited to the liver, because in healthy adults, hepatic cells rarely divide, probably once a year (49) . Hepatocytes that divide 30 times a year represent a hepatic cell population aging 30 times faster than the liver in healthy condition.
There is also a class of nongenotoxic carcinogens called tumor promoters. The best known tumor promoter is 12-0-tetradecanoylphorbol-13-acetate(TPA), isolated from croton oil. Other compounds with similar strong tumorpromoting activity in two-step carcinogenesis experiments in the dorsal skin of mice have also been reported. These are teleocidin from mycelia ofStreptomyces mediocidicus, lyngbyatoxin A from a blue-green alga, Lyngbya majuscula and aplysiatoxin from a blue-green alga, Lyngbya majuscula (50, 51) . All these tumor promoters share the same surface receptors and activate protein kinase C (51).
Okadaic acid, a polyether compound of a C38 fatty acid obtained from a black sponge, was also found to be a tumor promoter in mouse skin experiments, having the same potency as TPA (52) . However, unlike TPA and teleocidin, okadaic acid is a potent inhibitor of protein phosphatases, modulating phosphorylation of intracellular proteins, including some related to the cell cycle (53) . All these tumor promoters stimulate prostaglandin E2 synthesis (51) .
TPA, teleocidin, lyngbyatoxin A, aplysiatoxin, and okadaic acid are effective at microgram levels in carcinogenesis experiments when applied to mouse skin and exert many biological activities in vitro even at nanogram levels. However, there is, ironically, no evidence that these specifically functioning tumor promoters which have been most intensively studied in the international cancer research community have, in fact, any relation to human carcinogenesis, except for one paper describing a relationship between drinking bush tea and esophageal cancer in Caribbean people (54) .
More probably, common food components act as tumor promoters. For example, sodium chloride might enhance development of gastric cancer through damage of gastric mucosa and production of chronic gastritis (55) . In rat experiments, sodium chloride is reported to show a promoting effect in gastric carcinogenesis and to increase levels ofmalondialdehyde in both gastric mucosa and urine (56, 57) . Higher fat intake should yield a tumor-promoting condition for colon cancer development through more for mation of bile acid (58) and for breast cancer development through increased generation of estrogen by aromatase in adipose tissues (59) .
Recently, Long-Evans rats with a cinnamonlike coat color (LEC) were established. These LEC rats develop hepatitis spontaneously at 4 months old, and in those that overcome the acute phase and survive with chronic hepatitis, hepatomas develop at 1-1.5 years of age without exception (60) . It was found that copper accumulates in their livers and causes cell death and compensatory regeneration (61) . It is probable that this excess copper increases oxygen radical production, thereby causing continued turnover of hepatic cells and creating a favorable environment for hepatocarcinogenesis. It is noteworthy that hepatomas in LEC rats lack activation of any of the ras oncogenes (62) .
Multiple Genetic Backgrounds
Among many reports of cancer-prone families, one of the oldest records is probably that of gastric cancers in the Napoleon family (63) . In xeroderma pigmentosum, characterized by a deficiency in the molecular mechanism of DNA repair of pyrimidine dimers produced by UV, multiple skin cancers develop on exposure to sunlight (64) . Familial adenomatous polyposis coli, Wilms' tumor, and retinoblastoma families are also well documented as cases of neoplasia with a genetic background, and the genes responsible for these diseases have recently been identified (21, 23, (65) (66) (67) . Li Fraumeni syndrome is associated with a germ line mutation in the p53 gene. The mutated sites are in the region from amino acid codons 245 to 258 (68, 69) . Many other genetic diseases, including the Lynch syndrome and SBLA syndrome, have also been reported (70, 71) , but the genes responsible for these diseases have not been identified as yet. More or less nonspecific genetic abnormalities may also be involved in cancer development in cancerprone families, although the nature ofthe affected genes in cancer cells among families has not been completely elucidated.
In addition to heriditary alterations of genes in somatic cells, host factors are also important. These include genetic control of drug-metabolizing enzymes, such as cytochrome P450 (72, 73) , genetic polymorphism of acetylating enzymes (74, 75) , and the genetic background of histocompatibility (76 The presence of many types of anticarcinogenic substances in diet also requires inclusion in real risk estimation (80) . These substances are antioxidants, retinoids, indoles, aromatic isothiocyanates, and plant-originated polyphenols. Consideration of these factors is important to avoid overestimation of the risk of carcinogens. On the other hand, factors effecting tumor promotion should also not be overlooked. In the two-step initiation/promotion experiments, the carcinogenic effect of the genotoxic substance 7,12-dimethylbenz[a]anthracene painted on mouse skin could easily be enhanced about 100 times by subsequent treatment with croton oil or its active principle, TPA (81) . Similar promotion was observed for treatment of the dorsal skin of mice with a heterocyclic amine, 3-amino-imethyl-5H-pyrido [4,3-b] indole (Trp-P-2), and then TPA (82) .
Long-term experiments in animals on the effects of coadministrations of various kinds of genotoxic carcinogens are difficult to conduct. Ito et al. devised a new approach, "Ito's method," for medium-term tests using the rat liver (83) . Diethylnitrosamine treatment, partial hepatectomy, and then administration of a test substance results in the formation of glutathione S-transferase placental form (GST-P)-positive foci in the liver, the number and area of which can be measured using a color video image processor. This method requires a shorter period and fewer animals compared to long-term carcinogenesis experiments and is useful for screening hepatocarcino-gens and their inhibitory substances and for estimating risk of carcinogens. Ito et al. have used the method to examine the effects of combinations of five heterocyclic amines each at 1/25 and 1/5 of their carcinogenic doses, and found that in combination, these compounds exerted additive effects (84) . Probably many other carcinogens present in minute amounts in our environment are acting on our body in a similar way.
Another factor that requires consideration is the age at which exposure takes place. Thus it should be mentioned that neonatal mice are much more sensitive to heterocyclic amines than are adult mice (85) .
Multiple Primary Cancers
Recently, the cure rate of cancer has markedly increased, but second primary cancers often develop in patients whose first 
Multiple Approaches for Cancer Prevention
As discussed above, there are multiple genetic alterations, multiple carcinogenic steps, multiple environmental factors, and multiple primary cancers. This means that multiple approaches are not only necessary but also possible for cancer prevention. As multiple carcinogenic factors are involved, there is no single royal road to cancer prevention. The risk factor for any single compound determined even from exhaustive animal experiments is hard to apply in reality to humans. Even the background of the human populations is highly heterogeneous, not only genetically but also in cellular composition with regard to somatic cells with previous genetic alterations. Moreover, humans are exposed to many different types of carcinogenic factors simultaneously and/or successively.
A realistic and practical approach is to try to reduce the extent ofexposure ofhumans to carcinogenic factors as far as possible, unless this results in serious discomfort at the individual level or serious inconvenience at the community level, including economic burden to the nation. In the case of individuals, educated individual decision making should be encouraged with acceptance, at their own risk, of certain levels of exposure. In the case of the community, well-balanced committees of aware scientists, realistic economists, and critical sociopsychologists should decide pragmatically on suitable measures to prevent cancers without seriously affecting the development of societies, even though such decisions may be the targets of idealistic people. In other words, in some cases, it may be necessary to accept the presence of minute amounts of some carcinogens in our environment.
In fact, there are many examples of carcinogens in our ordinary, daily life that we must accept, irrespective of whether we are conscious of their existence (88, 89) . Wellknown examples are aflatoxin B1 in peanuts and their products and heterocyclic amines ubiquitously present in cooked meat and fish. However, exposure to these compounds could be reduced by more strict regulation of aflatoxin B1 and by appropriate methods to lessen the formation of the latter compounds in cooked meat and fish such as by use of microwave ovens and by wrapping meat and fish in aluminum foil to prevent charring. The avoidance of meat and fish contact with a naked flame and the removal of charred areas are also effective for lessening the intake of heterocyclic amines.
In cases of cancers due to viral infection, block of the route of viral infection is extremely useful: for instance, stopping breastmilk feeding for preventing HTLV-1 infection, careful screening of donor blood for HBV and HCV, and hygienic sexual intercourse for preventing HPV infection. In addition, vaccination is definitely an effective approach.
Generally speaking, the holistic approaches to improve- 
